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Abstract 
In recent times, psychedelics are back in the public eye, mostly through scientific intrigue 
about their healing potential. In the past decade, hundreds of studies have been conducted to 
explore the possible benefits, or risks, that these substances could bring to people – and there is 
great potential being found. This is the psychedelic renaissance, and with this phenomenon in 
full swing, it is important to take a step back and look at the full picture of our history with these 
substances. By doing so, it starts to become clear that psychedelics have guided human 
perception and understanding of our world for a very long time. The recognition of how 
important these substances are did not start last year or within the decade, or even back in the 
20th century with Albert Hoffman’s discovery of LSD. Humankind have been utilizing these 
substances for thousands of years – and the spiritual significance they contain for Indigenous 
people is almost unfathomable. That being said, the current psychedelic renaissance is being 
guided almost entirely by science and academia – as it has been since the colonization of 
Indigenous people, followed up by a Western takeover of the psychedelic healing paradigm 
starting in the late 1940’s. This literature review aims to catalog and make clear the role of 
Indigenous practices within psychedelic healing, and explores how a White-dominant scientific 
understanding of the same phenomenon has overshadowed these previous understandings, and 
why that is problematic. It’s not that one understanding is better than the other – but due to 
factors of structural racism, the same individuals who have been utilizing these healing practices 
for thousands of years are now being barred from the current conversations.  
There are multiple sections to this paper. First, there is an extensive history section that 
outlines both ancient history, as well as modern history starting in the 1940s and moving through 
to the present day. Then, to gain insight into our recent scientific understanding, I shall outline 
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the research behind why these substances are coming back into current conversations about 
healing. I will then make a case for the convergence of Indigenous knowledge and science, 
ending with a request to the scientific community to be more aware of the role BIPOC 
communities have in this renaissance – and to be aware that they are not being included as they 
rightfully should. By not including Indigenous voices and knowledge, we lose the thousands of 
years of experience and insight into the benefits these powerful substances can have, as well as 
possible risks and how best to avoid them.   
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Ancient History 
The history of psychedelics goes much further back in time and is deeper and more 
complex than many of those in the Western world might initially acknowledge (El-Seedi et al., 
2005), (Miller et al., 2019), (Rätsch, 2005), (Stamets, 1996). In this section I shall be outlining 
the ancient human history of three important plant medicines: psilocybin, peyote/mescaline, and 
Ayahuasca, as they are some of the most frequently documented substances from human history. 
I shall briefly discuss why each of these “entheogens” were so important to these peoples from a 
historical sociocultural standpoint. For clarity, entheogens can be described as any psychedelic or 
psychoactive drug that is taken for the express purpose of spiritual or religious practice (Ruck, et 
al., 1979). All three psychedelics referenced in the ancient history section of this paper are 
considered entheogens, as the Indigenous people that used them did so for spiritual reasons. I 
will then move on to more modern history, starting with the discovery of lysergic acid 
diethylamide - otherwise known as LSD. I will discuss the use and importance of LSD 
throughout the 1960s and 70s, and at the end of the movement related to U.S. President Richard 
Nixon and the “War on Drugs.” After that we will swing back around to the present, and discuss 
the current psychedelic renaissance.  
The purpose of this extensive history section is to show that psychedelic substances are 
important to humankind, and have been important for an extremely long time. They are very 
long-standing in our history, and have provided humans with a tremendous amount of 
information about ourselves and the world (Rätsch, 2005). Beyond that, as we will see in later 
sections, they may have significant roles in providing mental and physical health benefits - 
benefits similar to what we see reported in mindfulness practitioners (Frecska et al., 2016), 
(Simon & Engström, 2015). I will also briefly discuss what are known as “diseases of 
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civilization” (Bynum & Porter, 2006), and how psychedelics could help combat these ailments 
(Frecska et al., 2016). There will also be important acknowledgements of the current Western 
take-over of the psychedelic movement, and how that could be harmful to the Indigenous groups 
that were first to utilize psychedelics (George, et. al, 2020). My aim is to make the case that the 
psychedelic renaissance is important, and should be bolstered (safely), as well as ensuring that 
BIPOC individuals with psychedelic history and meaningful experience do not get cut from the 
discussion.  
Psilocybin  
 Perhaps one of the best-known psychedelics is the fungi-sourced psilocybin – more 
commonly known as “magic mushrooms.” It turns out there are reasons it is very well known: to 
start, these mushrooms grow in every single continent except for Antarctica. They are incredibly 
widespread and normal to find growing just about anywhere mushrooms grow – the most 
common areas being wetter, more tropical locations. This is according to a review of the world-
wide distribution of psychoactive mushrooms (including but not limited to psilocybin containing 
specimens) conducted in 2000 by Gaston Guzman, et. al., which recorded not only the number of 
distinct species of hallucinogenic mushrooms, but also catalogued where they grow. There are 
over 200 species of Basidiomycota mushrooms that contain psilocybin, the largest genera out of 
eleven being Psilocybe, with over 116 species (Guzman et al., 2000). The bulk of these grow in 
Mexico (with 53 separate species being found), but are also located in the Northern Americas, 
Europe, Asia, Africa, and Australia (and surrounding islands). This means that people all over 
the world have had access to hallucinogenic mushrooms, psilocybin containing or otherwise - 
such in the case of the Amanita muscaria mushroom, which was an important entheogen of the 
Indigenous people of Siberia (Nyberg, 1992).  
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 This brings me to my next point: these mushrooms have been making incredible impacts 
on the people who consume them for thousands of years. One of the first instances in ancient 
human history that we can tangibly see (not to say that they didn’t have importance before then), 
are the Mayan “mushroom stones” of Guatemala – carbon dated to 1000 BCE. These statues 
were excavated from Mayan ruins and were a clear sign of how revered these mushrooms were 
to the people (Borhegyi, 1961). Beyond that, the Aztec even had a word for a species of 
Psilocybe mushrooms that they called teonanacatl, otherwise known as “God’s Flesh” (Stamets, 
1996). They considered the mushrooms to be holy sacraments, and had several ceremonies and 
rituals tied to consuming them. These ceremonies were noted by the Spanish invaders who came 
to conquer Mesoamerica in the 16th century, but then were promptly forbidden by said invaders, 
in the name of squashing anything they considered to be “satanic” or “pagan idolatry.” (Stamets, 
1996). In fact, they tried their best to completely suppress not only the rituals, but anything 
related to reverence for the mushroom, included the aforementioned Mayan statues. The deep, 
rich and complex history of the mushroom to these people was nearly wiped out entirely 
(Stamets, 1996). This is a shame, and also quite interesting to me, considering that the same 
world that effectively wiped out the already established power of psychedelics is the same world 
that now can’t get enough of it. This will be touched on later in this literature review, however. 
For now, the point is that these psychedelics are important to people. This is clear before we 
even gain an understanding of the science of why they might be so important. 
Peyote/Mescaline 
This next substance is less ubiquitous than psilocybin but undoubtedly just as important 
to the peoples who have consumed it for thousands of years. Mescaline is a psychedelic 
compound that is extracted, usually through means of cooking, from the Peyote cactus, the San 
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Pedro cactus, and a couple less well-known cacti. These cacti and the resulting extracted 
compound have been used for at least 5,700 years by Native American populations in pre-
colonized Mexico, part of which is now known as Texas. This data was gathered through carbon 
dating mescaline “buttons” that were found with other significant cultural material (El-Seedi et 
al., 2005). Similar to psilocybin, this psychedelic protoalkaloid1 holds significant religious and 
cultural importance to the groups who used it in ritual practice.  
One of the first historical documentations of the use of mescaline was recorded by 
Spanish colonizers around the late 1600’s and early 1700’s (Jones, 2007). This way of life 
continued to be up-rooted during the 1800’s, as tribes were forced away from their homelands 
into new, unaccommodating conditions – a place where mescaline containing cacti did not grow. 
Through this restriction came a retaliation, however; peyote was slowly being re-introduced into 
their lives via horseback trading, and peyote rituals went from unnamed but commonly practiced 
rituals to the creation of an entire church based around the cactus. It is unclear exactly which 
tribe established the NAC (Native American Church), but the church’s main goal was to protect 
and strengthen the Native American right to perform peyote rituals (Jones, 2007).  
The NAC served as a way to band together tribes and individuals under symbology and 
meaning – but beyond that, peyote rituals served to provide a “needs‐based solution to 
psychological problems Native Americans were encountering in the newly enforced reservation 
system” (Jones, 2007). In this case, the consciousness-expanding power of mescaline would help 
NAC members to “heal physical, mental, and spiritual imbalances within themselves and among 
their social relations, helping to assuage the effects of the needs‐denying arrangements of the 
 
1 A protoalkaloid is a type of alkaloid (a naturally occurring organic compound produced by living 
organisms including plants, bacteria, fungi and animals) originating from amino acids. Many 
protoalkaloids are also psychoactive in nature (Aniszewski, 2015).  
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reservation system” (Jones, 2007). The point here is that despite any attempts to quell or 
suppress the use of psychedelics, those who are able to harness its power for healing will fight 
for their right to do so, regardless of how difficult that fight may be. This again points to the 
importance of psychedelic compounds to these individuals.  
Ayahuasca 
Ayahuasca, otherwise known as the “vine of the soul” in the Quechua language (Luna, 
2011) is a brew made by the Indigenous peoples who reside in the Amazon basin. The primary 
psychoactive compound contained within the brew is N,N-Dimethyltryptamine (more commonly 
known as DMT) which is extracted from the Psychotria viridis shrub (or other DMT containing 
plants) through a process of boiling (Riba et al., 2003). This preparation is more than simply 
DMT, however. What sets Ayahuasca apart from other DMT preparations is the inclusion of the 
Banisteriopsis caapi vine. This vine, when boiled, releases a monoamine oxidase inhibitor 
(MAOI), a type of psychoactive compound that is quite well known in the United States and 
around the world for its anti-depressant effects. These specific alkaloids contained within the 
vine are known as harmine, harmaline, and tetrahydroharmine (Riba et al., 2003). These 
alkaloids prevent deamination of DMT in the gut when combined, meaning that the DMT does 
not break down as easily and this leads to more exposure, with stronger and longer lasting effects 
(Ruffell et al., 2020).  
As with psilocybin and mescaline, it is impossible to know the true ancient history of its 
use, although it is speculated to reach back millennia. However, there is physical evidence of the 
use of Ayahuasca dating back to 1,000 years ago. This evidence was extracted and carbon-dated 
from what was deemed a “ritual bundle,” a fox-snout pouch carefully stitched together, implying 
the importance of it as an entheogen to the Indigenous folks who partook (Miller et al., 2019). 
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Aside from physical evidence, we also have anthropological evidence stemming from Spanish 
and Portuguese colonizers who demonized and attempted to fully eradicate Ayahuasca rituals 
from Indigenous South America (Soibelman, 1995). We can start to notice a theme here: 
Indigenous cultures discover and have significant use for these entheogens which they utilize for 
thousands of years, until the Western world attempts to abolish anything they consider to be 
“satanic” in the name of Christian theology (Stamets, 1996). This is important to realize as the 
psychedelic renaissance continues to unfold within the Western world - these substances have 
been around for much, much longer than we may give credit for.  
Modern Western History of Psychedelics 
Just as it is important to recognize the ancient world history of psychedelics, we must 
also acknowledge the more recent and scientifically based Western understanding of these 
fascinating compounds. I would like to note that neither approach is necessarily more valid, and 
that both perspectives may contribute to a richer and more insightful understanding of the 
meaning and significance of these substances to humankind.  
Albert Hoffman’s Discovery of LSD  
 An appropriate place to start when considering the scientific history of psychedelics 
(mainly due to the historical significance and popularity of this event) is the discovery of an 
important chemical compound - one that would change the life of its discoverer and many people 
after him: that being Albert Hoffman’s discovery of Lysergic Acid Diethylamide, otherwise 
known as LSD. As stated in Hoffman’s 1996 speech LSD: Completely Personal, the initial 
synthesis happened on November 16th, 1938. Hoffman was experimenting with ergot alkaloids to 
“obtain a novel, improved circulatory stimulant” (Hoffman, 1996). At first, he was unsure of its 
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efficacy for much of anything, and left the chemical synthesis alone for the next five years, until 
one day he had the urge to experiment with the substance again. He recounts that his first 
exposure was accidental, and so on April 19th, 1943, he purposely dosed himself and went on 
what he described as a “horror trip.” While that sounds unpleasant at best, that didn’t stop him 
from realizing LSD’s potential and he continued to study the chemical. (April 19th is now 
affectionately known for many who partake as “Bicycle Day,” in reference to Hoffman’s ride 
home while under the influence.)  
He later describes his “horror trip” as frightening at points, but also enlightening 
(Hoffman, 1996). This leads to the modern idea that there is no such thing as a “bad trip,” but 
rather challenging trips that can be learned from. Michael Pollan, a modern (and quite popular) 
psychedelic researcher and writer, and Bridget Huber, his research assistant, write about their 
findings of a Johns Hopkins survey taken on the challenging experiences people had under the 
influence of psilocybin: “…interestingly enough, despite these negative experiences, many of the 
survey respondents still found even these bad trips to be meaningful and spiritually important. 
For 34 percent of participants, their most challenging trip on psilocybin was ranked among the 
top five most meaningful experiences of their life. And 31 percent said it was among the top five 
most spiritually significant experiences of their life. Eighty-four percent of the respondents said 
they had benefited from the challenging parts of their trip and 46 percent said they would repeat 
that session if they could, despite the challenges” (Huber & Pollan, 2020).  
 So being that Albert Hoffman was a Swiss scientist, how did LSD make its way over to 
the United States? Well, to start, the Swiss laboratory that held its discovery was intrigued by 
LSD’s possible usefulness, and thus became a commercially available medication (under the 
name Delysid) for a variety of different psychiatric uses in 1947, following the 1943 patent of the 
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substance (Hoffman & Stoll, 1943). Then in 1949, the same laboratory that assigned the patent in 
Switzerland brought the US government to the attention of LSD citing possible usefulness in 
clinical applications, that laboratory being Sandoz Laboratories (Pollan, 2019). This introduction 
launched a decades long battle for and against LSD on all sides (civilian, government, and 
scientific.) Even Time magazine published six separate reports about the positive benefits of 
LSD, from 1954 to 1959 (Shafer, 2010).  
 There is a sizeable amount of LSD history contained within the decades of the 1950 and 
1960s, and so I will do my best to keep the information concise. Essentially, throughout the 
1950’s, there were a growing number of researchers looking at the possible uses of LSD, starting 
with a method of producing “model psychosis,” through which mental illness could be studied. 
This is indicative of the approach towards psychology at the time, which was primarily focused 
on the “illness” side of mental illness (Langlitz, 2006). An important name throughout all this is 
Sidney Cohen, a leading research authority on LSD in the 1950’s. After having taken the 
substance for the first time on October 12th, 1955, he recounts his experience as being 
surprisingly positive, considering the current mental illness rhetoric that was being pushed by 
fellow researchers, as we can see here:  
“[Cohen] expected to feel catatonic or paranoid, but instead, he wrote, ‘I was taken by 
surprise. This was no confused, disoriented delirium, but something quite different.’ His 
subsequent report described feeling an elevated peacefulness, as if ‘the problems and strivings, 
the worries and frustrations of everyday life vanished; in their place was a majestic, sunlit, 
heavenly inner quietude.... I seemed to have finally arrived at the contemplation of eternal truth’” 
(Novak, 1997). After this personal discovery he teamed up with another important name in 
psychedelic history: Aldous Huxley. Together with Betty Eisner, the team explored whether or 
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not LSD could be helpful to facilitate psychotherapy, address alcoholism and enhance creativity 
(Novak, 1997).  
Studies continued on into the 60s and even the mid-70’s as LSD grew in popularity, both 
among the masses and among academic researchers. This includes Richard Alpert, better known 
as Ram Dass, who was also experimented on using LSD during MK Ultra2; and Timothy Leary, 
a psychology professor at Harvard, who is known for his activism in making LSD publicly 
known and revered among counterculture groups at the time. The two worked together to 
perform dubious (by today’s standards) scientific research at Harvard, until they were both 
kicked from the school altogether, fueling Leary’s activism. This advocacy, however, may have 
backfired – as even Albert Hoffman states in his book LSD: My Problem Child:  
“The evolution of LSD from remedy to inebriating drug was, however, primarily
 promoted by the activities of Dr. Timothy Leary and Dr. Richard Alpert of Harvard
 University” (Hoffman, 2009).  
This brings me to an important aside. These substances are powerful - and cannot and 
should not be taken or given out with negligence. With great power comes great responsibility - 
and I’m afraid that, at least in their years of research, Timothy Leary and Richard Alpert did not 
do their due diligence to keep people safe and to keep their research sane (Hoffman, 2009). 
According to Hoffman’s firsthand accounts of his 1970s meetings with Dr. Leary, the LSD 
apostle (as he was known at the time) had slipped away from pure scientific method and into his 
 
2 MK Ultra was a US governmental CIA program that wrongfully and destructively experimented with 
LSD on vulnerable subject groups – including mentally ill patients, prisoners, drug addicts and sex 
workers in the 1950’s. The group claims this was necessary in order to determine if LSD was effective as 
a “truth serum” they could use on prisoners of war. All of this is considered extremely unethical by 
today’s research standards (Linville, 2016).  
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own “experimentation,” hosting LSD parties that were far removed from their original scientific 
purpose (Hoffman, 2009). Hoffman describes him as a passionate person who is very sure of his 
mission – so much so that he had lost sight or frequently overlooked the potential downfalls or 
risks to psychedelic therapy (Hoffman, 2009). This is part of the reason we must move forward 
into further psychedelic research with the utmost care and consideration. Because of institutional 
review boards (IRBs), which engage community members to help evaluate research proposals 
before approval and require informed consent, research is done more ethically today. There is no 
reason to blindly fear these substances – it just pays to be mindful.  
The War on Drugs 
Due to in part of the unfortunate mishandling of these powerful substances, in the year 
1966 LSD was declared a Schedule 1 substance, the most illegal a drug could be (Affairs, 1999). 
Richard Nixon, elected as the President of the United States in 1969, is perhaps best known for 
his involvement in the Vietnam War, his Watergate scandal that lost him his presidency and 
credibility and for starting the global campaign known as the “War on Drugs,” that continues to 
this day – despite the controversy that surrounds it (Gonzalez et al., 2019).  
While a “War on Drugs” may perhaps at first sound like a helpful thing which could 
prevent addiction and general harm to users, there are many underlying problems at play here. 
Perhaps most importantly, the war on drugs could be argued as not a war on drugs, but a war on 
people that the government deems less desirable. This included those struggling with drug use 
disorders, who are themselves generally viewed by the Drug Enforcement Agency (DEA)  and 
other governmental agencies as dangerous criminals, rather than people with mental illness who 
need help, thanks to the stigma that the war on drugs helps perpetuate (Buchanan & Young, 
2000) – but notably this also includes and disproportionally affects POC, particularly low-
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income Black and Latinx communities (Rosino & Hughey, 2018). This is an element of a much 
larger, systemic problem that we face in our current culture, that being structural racism. Before 
we can recognize the role of structural racism in the War on Drugs, we must first gain an 
understanding of what structural racism is.  
From a 2004 presentation written by Keith Lawrence and Terry Keleher for a Race and 
Public Policy Conference: “Structural Racism in the U.S. is the normalization and legitimization 
of an array of dynamics – historical, cultural, institutional and interpersonal – that routinely 
advantage Whites while producing cumulative and chronic adverse outcomes for people of color. 
It is a system of hierarchy and inequity, primarily characterized by White supremacy – the 
preferential treatment, privilege and power for White people at the expense of Black, Latino, 
Asian, Pacific Islander, Native American, Arab and other racially oppressed people” (Lawrence 
& Keleher, 2004). Structural racism is embedded into the very fabric of society, and affects 
BIPOC (Black Indigenous People of Color) on nearly all levels – but particularly when it comes 
to health inequities (Bailey et al., 2021). Structural racism is not just about prejudices held by 
individuals, but goes beyond that into the production and reproduction of laws, rules, and 
practices that are enforced and upheld by governmental institutions, within economic systems 
and in social and cultural norms (Bailey et al., 2021), (Bailey et al., 2017), (Rothstein, 2017).  
In a 2018 study of the War on Drugs and its relation to structural racism, authors Michael 
L. Rosino and Matthew W. Hughey have taken 30 years’ worth of news content relating to the 
topic and from there proposed a framework that “considers the history of racially motivated laws 
and practices and moral panics among Whites who have blamed drug-related social problems 
and crime on marginalized racial groups” (Rosino & Hughey, 2018). They argue that drug law 
enforcement is unnecessarily violent, forceful, and usually ends in imprisonment - which hits 
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marginalized groups particularly hard and lends itself to perpetuating structural racism (Rosino 
& Hughey, 2018). They outline a growing body of research that examines the “racialization and 
expansion of the American justice system and its social ramifications” (Rosino & Hughey, 
2018). Essentially, their findings point to racial oppression in the United States related to the 
racialization and militarization of drug enforcement policies. Marginalized communities are 
targeted due to the fear around racial groups as being threatening or dangerous, even though 
Whites tend to engage in more drug offenses than their BIPOC counterparts:  
“Empirical evidence overwhelmingly demonstrates Blacks are targeted for arrest and 
punishment in disproportion to their actions relative to Whites. However, many politicians, legal 
authorities, members of the public, and even criminologists fail to identify racial prejudice and 
discrimination as systemic factors in criminal justice” (Rosino & Hughey, 2018).  
As is evident from the article, the War on Drugs has had devastating effects on the exact 
communities that need to be protected. I feel that it is of the utmost importance that one of the 
goals of the modern-day Psychedelic Renaissance should be to recognize these elements of the 
fight against the War on Drugs, considering the White-dominant medical framework that resides 
at the forefront of the renaissance. Indigenous communities have always utilized psychedelics in 
very deeply meaningful ways, so I believe that we must strive to include BIPOC individuals in 
our conversations.  
The Psychedelic Renaissance 
 It appears that within the past 10-20 years, psychedelics are once again gaining ground in 
the psychological and psychiatric world as powerful tools of healing (Giffort, 2020), (Sessa, 
2017). In this section I discuss relationships between brain function and structure, including the 
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connection between depression, anxiety, and addiction and what is known as the “Default Mode 
Network” of the brain. Psychedelics have the ability, under proper conditions and care, to help 
assuage the effects of a malfunctioning Default Mode Network that contributes to all of these 
mental ailments. These links shall be made evident through psychological studies, which are 
described below.  
The Science Behind Psychedelics  
A General Overview of the Default Mode Network  
In order to understand how psychedelics could possibly benefit someone suffering from 
symptoms of depression, anxiety and/or drug use disorders, we must first begin to understand 
why we have these symptoms in the first place. Naturally, these mental ailments are incredibly 
complicated, and so for the purpose of this paper, we shall be focusing on a very specific 
function of the brain in order to keep it concise. This function, and the network of brain regions 
involved, is known as the Default Mode Network (hereby referred to as DMN). Essentially, the 
DMN is a collection of areas within the cerebral cortex that are responsible for resting-state 
activity within the brain. Whenever you are not focused on an “attention-demanding, goal-
directed” task, i.e., you are in a “resting” brain state (often described in research articles as the 
“control” condition); the DMN is active, and is responsible for “self-referential processing and 
mind-wandering” (Raichle, 2015). This refers to both self-evaluation, as well as perceived 
evaluation from others (otherwise known as social evaluations). This can clearly be an active 
“resting” state. If you have ever wondered why you cannot seem to shut your brain off at 2 am, 
wanting to sleep but instead thinking about that one time in 8th grade where that embarrassing 
thing happened – you can thank your DMN for that.  
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Beyond the classical understanding of the DMN being an ‘intrinsic system’ – meaning 
that it’s an internally oriented process of the brain responsible for self-reference, daydreaming, 
and thoughts about the past and future – the DMN may also be a ‘sense-making’ network 
(Yeshurun et al., 2021). The two functions seem to work in tandem with one another: “…the 
DMN is an active and dynamic ‘sense-making’ network that integrates incoming extrinsic 
information with prior intrinsic information to form rich, context-dependent models of situations 
as they unfold over time” (Yeshurun et al., 2021). It is still true that the DMN is active during the 
brain’s resting state, but it has been suggested that “the response of the DMN is locked to 
external stimuli, especially during social interactions, and thus can be considered extrinsic… the 
DMN is at the nexus of the interaction between the external and internal worlds” (Yeshurun et 
al., 2021).  
There is evidence that sufferers of depression, anxiety and substance use disorders all 
have altered DMN functionality (Coutinho et al., 2015), (Sheline et al., 2009), (Zhang & 
Volkow, 2019). The exact type of disfunction varies between ailments, but it has been shown 
that all three alter the regular resting state activities of the brain. In depression, it has been shown 
that sufferers fail to normally down-regulate DMN activity, as well as having heightened 
responses to stimulus-induced negativity (Sheline et al., 2009). This means that these individuals 
are more receptive to negative evaluations of their world, and have a harder time shutting down 
those evaluations (Sheline et al., 2009). As for anxiety, the results are fairly similar. For both 
depression and anxiety, the same areas and functions have been shown to be altered. 
Specifically, the functional connectivity within the anterior portions of the DMN which are 
related to self-referential and emotional processes were found to be positively correlated with 
those suffering from anxiety and depression (Coutinho et al., 2015). However, the posterior areas 
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related to episodic memory and perceptual processing were found to be negatively correlated 
(Coutinho et al., 2015). In more simplified terms, individuals suffering from depression and 
anxiety are spending more time thinking about and ruminating on social evaluations and 
emotions, and have a harder time perceiving and remembering events “correctly” (Coutinho et 
al., 2015). 
As for substance use disorders (SUDs), it has been shown that the DMN is again not 
functioning normally, and this dysfunction is associated with cravings and relapse (Zhang & 
Volkow, 2019). Specifically, the resting functional connectivity of the anterior DMN (which as 
we learned above, is related to self-referential and emotional processes) decreases, which leads 
to poor emotional regulation (relapse) and less care towards the self, allowing one to give in to 
cravings without thinking of the negative consequences that action may have on the self (Zhang 
& Volkow, 2019). On top of that, the DMN as a whole is overly active during withdrawal and 
when in a resting state, leading addicted individuals to ruminate about taking the substances they 
are currently withdrawing from (Zhang & Volkow, 2019). We also see disrupted connectivity 
between the DMN and cortical regions that deal with executive functioning and memory, making 
it difficult for the addicted individual to fully perceive and understand the effects their substance 
use disorder is having (Zhang & Volkow, 2019). All of this together leaves these individuals in a 
battle against their own brain and chemistry.  
Psychedelics and Meditation as Possible Solutions 
Now that we know the role the DMN plays in these three afflictions, we can start to look 
into methods that help reduce dysfunction in the DMN. Interestingly, both the influence of 
psychedelics on the brain, as well as meditation and other mindfulness techniques can have 
positive therapeutic results in treating mood disorders, even for treatment resistant individuals 
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(Kelly et al., 2019), (Kenny & Williams, 2007). First, let’s focus on psychedelics. According to a 
2018 literature review published on the effects of psychedelics (psilocybin, lysergic acid 
diethylamide, ketamine, and ayahuasca) on the DMN, there are significant alterations within the 
function of the DMN that may mark the efficacy of psychedelic-assisted psychotherapy. 
Fascinatingly, the DMN has been shown to function in the exact opposite way than it does in 
mood disorders when sufferers are under the influence of psychedelics (Ruban & Kołodziej, 
2018). To clarify, the DMN is found to have increased activity of main nodes, as well as 
abnormal functional connectivity when afflicted by mood disorders. Under the influence of 
psychedelics, however, the DMN activity is leveled and positive coupling between main nodes is 
reduced. This points to a potential functional mechanism for psychedelics’ effectiveness in 
combatting mood disorders related to the DMN (Ruban & Kolodziej, 2018).  
A study conducted in 2016 by Carhart-Harris at the Imperial College London has shown 
that an amazing “sixty-seven percent of participants with treatment resistant depression had 
significantly reduced depression symptoms at 1 week, with 40% of participants showing a 
sustained response at 3 months post-dose” (Kelly et al., 2019). This is an important finding, 
considering that treatment resistant depression is just that: treatment resistant. From my own 
experience talking with people experiencing treatment resistant depression, it can be outright 
debilitating – so these findings are hugely significant for this population. In fact, the Food and 
Drug administration granted psilocybin ‘breakthrough therapy’ status in 2018, and in 2019 and 
2020 respectively, Colorado and Oregon decriminalized the possession of psilocybin (Ordinance 
301, 2019), (Measure 109, 2021). Once rules are established, permit holders can conduct 
psilocybin-assisted therapy within specified centers of healing.  
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Slowly but surely the Western world, driven by ethically bound science is catching on to 
the knowledge that Indigenous people have understood for thousands of years. Another ancient 
knowledge that is being “rediscovered,” within the context of healing mood disorders such as 
depression and anxiety, are meditation and mindfulness techniques. Interestingly, mindfulness 
evokes similar changes in the brain as psychedelics, specifically within the functionality of the 
DMN. Since we can already start to look at specific dysfunctions of the DMN as a biomarker for 
diagnosis, we can also start to look at changes within that functionality during the course of 
treatment, as a biomarker for the efficacy of said treatment (Simon & Engström, 2015). This was 
shown to be accurate with psychedelic-assisted therapy (Ruban & Kołodziej, 2018); although 
more research is certainly required in order to make any conclusive statements. Specifically for 
the case of meditation, modulation of the DMN is the highest predictor of efficacy for treatment. 
In other words, the practice of meditation helps a person suffering from rumination quell their 
overactive thought processes (Simon & Engström, 2015).  
Researchers have been looking into ways to combine psychedelic-assisted psychotherapy 
and mindfulness techniques, considering the potential that both treatments have, as well as the 
similarities between how they impact the brain. This research is quite new, and as such must be 
tested, as we can see in a 2019 study looking at psilocybin-assisted mindfulness training 
conducted by Smigielski, et al. They set up a randomized, placebo-controlled, double-blind study 
in which 38 participants were given a single dose of psilocybin before a 5-day mindfulness 
retreat. (As an aside, an interesting phenomenon about psychedelics is that they tend to provide 
long-lasting benefits (Nichols et al., 2016), and so one dose over the span of 5 days can certainly 
be enough to maintain effects.) The researchers started with an fMRI to gain a base level 
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understanding of DMN functionality within the participants, and then scanned them again during 
resting-state activity as well as during two forms of mindfulness training.  
It was found that the psilocybin had a synergistic effect with the mindfulness therapy 
sessions. Specifically, the regions of the DMN that mediate a sense of self were found to be 
decoupled during the psilocybin-assisted mindfulness sessions, those regions being the medial 
prefrontal and posterior cingulate cortices – areas which both psilocybin and meditation affect 
(Smigielski et al., 2019). This decoupling from both psilocybin and mediation is associated with 
a subjective ego dissolution effect, which in turn predicted “positive changes in psycho-social 
functioning of participants 4 months later” (Smigielski et al., 2019). As it turns out, the common 
psychedelic moniker of “ego death”3 can indeed be tracked in the brain, on top of being able to 
physically track the positive effects that an experience of ego death may have.  
Diseases of Civilization  
Going along with our theme of Western, science-based knowledge and its modern 
convergence with ancient or Indigenous knowledge, I would like to briefly discuss what are 
known as “diseases of civilization” – and then how psychedelics may play a role in helping us 
overcome these diseases. Technically it can be said that all diseases that affect any civilization at 
any period of time can be considered diseases of civilization. However, there are specific 
diseases linked to modern-day Western life, such as heart disease and obesity through a high 
sugar, high fat diet or unequal access to healthy food or opportunities for exercise and 
preventative care (Bynum & Porter, 2006).  In fact, it is often those who have inadequate access 
 
3 As described by Timothy Leary in “The Psychedelic Experience,” a psychedelic “ego death” is the 
experience of a “complete transcendence” of the self, in which a sort of death and rebirth of the self can 
occur (Leary et al., 1966).  
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to healthy living (those living under the poverty line, full-time minimum wage workers with 
families to feed and racially discriminated groups) that suffer the most from diseases of 
civilization, due to environmental aspects of poor working conditions and stress – among other 
factors (Bynum & Porter, 2006).  
 These diseases go beyond the physical, as one could imagine, and into the psychological. 
This includes depression, anxiety, ADHD, drug use disorders and more. Combatting these 
afflictions under the lens of civilization being the root cause seems like a practice in 
hopelessness, considering the overarching structures of capitalism that keep us firmly rooted in 
this type of civilization (Matthews, 2019), (Olivier, 2015), (Prins et al., 2015). There may be 
hope, however, contained within a specific ancient knowledge that was discussed at the 
beginning of this paper – that knowledge being the ritual use of Ayahuasca. This is according to 
a literature review conducted in 2016 by Frecska et al., in which the researchers compiled 
information pertaining to what Ayahuasca is, what it does to the brain and body, and whether or 
not these effects are therapeutically and possibly physically beneficial. Specifically, they studied 
its effects against diseases of civilization. For the purpose of this paper, I will focus on the 
psychological side, but there is also significant evidence pointing towards a possible role of 
DMT in tissue protection and neuro-regeneration, as well as in protection against possible Sig-
1R receptor related diseases such as cancer and Alzheimer’s disease (Frecska et al., 2016).  
A common physiological thread between most diseases of civilization (physical or otherwise) 
is chronic Low Oxidative Inflammation (LGI). LGI is caused by constant psychological stress 
(such as poor working conditions with little to no access to therapy and time off), environmental 
pollution, and even smoking behaviors. LGI is implicated in a number of degenerative diseases, 
such as autoimmune diseases, cancer, Alzheimer’s, and most notably for the case of this paper, 
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major depression (Aseervatham et al., 2013), (Frecska et al., 2016). Without getting into the 
complicated neurobiology of it all, it’s important to note that Ayahuasca acts on the Sig-1R 
receptor in a way that helps alleviate the degenerative impacts of LGI on cellular processes. In 
other words, LGI causes cellular stress, which over time can have severe effects on the brain and 
body. Ayahuasca can potentially act as a broad-spectrum remedy, “which hits the dead center of 
the discussed vicious circle of the malfunctioning molecular web involved in oxidative stress” 
(Hayashi, 2015), (Frecska et al., 2016).  
There is evidence that Ayahuasca may also help those suffering from substance use disorders 
due to its direct and indirect effects on both dopaminergic and serotonergic systems: “…the 
resolution of addiction through ayahuasca’s therapeutic potentials may act on four levels: (1) 
reducing brain DA (dopamine) level in the MDP (mesolimbic dopamine pathways) through 
effects on the 5-HT (serotonin) receptors, which in turn (2) interferes with the synaptic plasticity. 
This neurochemical mechanism is supported by (3) psychological insights and processing of 
repressed traumas, enhancing decision making capabilities, which allows the person to (4) 
examine first person transcendental experiences” (Frecska et al., 2016). Let’s break down what 
this particular researcher is proposing; thanks to certain mechanisms that Ayahuasca exerts on 
the brain, this powerful psychedelic might allow an individual suffering from substance abuse 
disorders to gain new insight into the root cause of their addiction (trauma) and hopefully, with 
support, overcome it.  
As for other mental afflictions, Ayahuasca works similarly, reportedly bringing forth deeply 
buried subconscious material in a way that sometimes helps the individual learn about 
themselves via illumination of perspectives previously unknown and unseen. This helps the 
individual gain insight into maladaptive behavior or emotional and cognitive patterns that are 
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otherwise ingrained, and difficult to shake (Frecska, et al., 2016). Ayahuasca helps to encourage 
the individual to acknowledge their ingrained emotional and cognitive patterns – and thus offers 
the understanding needed to change maladaptive behaviors and thinking (Loizaga-Velder & 
Verres, 2014), (Frecska, et al., 2016).  
Perhaps Ayahuasca could help heal the ailments that a modern day Western life can produce. 
However, there are many considerations that the scientific world must investigate if we go 
forward with this type of therapy. We must recognize that the current frameworks of psychedelic 
psychological studies and professions are White-dominant (Buchanan, 2020). Not only that, but 
the current models and theories for treatment are framed within the White experience, in that 
there is little to no understanding of the needs and worldviews of BIPOC individuals – and thus 
is generally unhelpful to these populations. (Buchanan, 2020). We must take extra steps to 
ensure that low SES and disadvantaged groups, such as BIPOC receive just as much benefit from 
this type of healing as their White counterparts. This is especially true as the world of Indigenous 
psychedelic use is increasingly appropriated (Labate & Conrad, 2019).  
Considerations Towards the Future 
The Role and Current Exclusion of BIPOC in Psychedelic Healing  
To recap what we have learned so far: psychedelic healing has been an important part of 
Indigenous cultures long before Albert Hoffman and the current psychedelic renaissance. That 
being said, the scientific basis of the Western understanding of psychedelics is necessary to more 
clearly understand what these substances can do for us, and how to keep individuals needing 
treatment safe while undergoing psychedelic therapy. Unfortunately, Indigenous peoples are 
being left out of this conversation, partly due to the White-dominant medical framework that 
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psychology work resides within – considering that the workforce and trainee pipeline are 
majority White (APA, 2018). Furthermore, BIPOC communities are not receiving the same level 
of benefit from the psychedelic renaissance as White communities (Buchanan, 2020), in that 
over 80% of participants in trials are White, with less than 3% being Black (Michaels et al., 
2018). So, what can the individuals with the power of privilege and academia on their side do to 
ensure that everyone receives the same treatment? The first step is to listen to BIPOC people and 
to learn. As such, let’s take a look at an article written by George, et. al, in 2020 about “The 
psychedelic renaissance and the limitations of a White-dominant medical framework: A call for 
indigenous and ethnic minority inclusion” (George et al., 2020).  
Essentially, there are a few cultural and social forces that have led to the suppression and 
even silencing of Indigenous and minority voices within the scientific psychedelic community. It 
started in the 1950’s and 1960’s with the appropriation of psychedelics by the White “hippies” of 
the time, who specifically wanted to transform themselves with the drugs, music, and 
spiritualities of other populations (George et al., 2020), (Saldanha, 2007). Despite their 
fascination with other cultures, hippies failed to understand the damage they were doing to the 
exact culture they wanted to appropriate, via the perpetuation of negative stereotypes (Lemke-
Santangelo, 2010). While hippies were trying to transform themselves through transcendental 
means, Black and Indigenous populations were being viewed as dangerous, “druggie” criminals 
for wanting to do the same or just for being themselves (Williams, Gooden, & Davis, 2012).  
More recently, we have mass incarceration of BIPOC individuals and communities that 
essentially perpetuate a new type of classist segregation, known as the “New Jim Crow” (George 
et al., 2020). BIPOC are more likely to be arrested and charged much more harshly (with longer 
sentences) for drug crimes than their White counterparts – despite similar rates of drug usage 
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(Forman, 2012). With the fear of life-long imprisonment (or the effects of short term 
incarceration on their lives moving forward, such as decreased access to housing and jobs) 
looming over their shoulders, BIPOC communities can’t even begin to think of psychedelic 
treatment as viable options (George et al., 2020). Furthermore, problems within BIPOC 
communities are not seen as problems until the same issues start to affect White communities – 
and as such are not recognized until the problems are deeply set (George et al., 2020). Beyond 
that, with a history of understandable mistrust towards medical treatments, thanks to horrific 
instances like the Tuskegee Syphilis experiments, it is no wonder that the benefits of psychedelic 
therapy are not reaching BIPOC communities (George et al., 2020). There is significant work 
that needs to be done in recognizing the effects of these traumatic events, and part of that is 
ensuring that BIPOC are part of the conversation about psychedelic healing going forwards.  
Conclusion 
My aim is to make the case that the psychedelic renaissance is important and should be 
bolstered (within the safest means possible), as well as ensuring that BIPOC individuals with 
psychedelic history and meaningful experience do not get cut from the discussion. There is 
scientific evidence that psychedelic therapy could greatly benefit society going forward. But we 
must be aware of and include the role of Indigenous knowledge in this shift, considering the 
great amount of history these communities have with these substances. It’s also important to 
know that right now the benefits of the psychedelic renaissance are not reaching BIPOC 
individuals and communities thanks to structural racism and a White-dominated psychological 
workforce, among other factors. My hope for this literature review is to bring awareness to the 
current gap in accessibility for this therapy, and to demonstrate why we must push for change.  
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